1. Circulating Tumor Cells as a Tumor Stage Independent Biomarker for Diagnosis, Prognosis, and Disease-monitoring in Pancreatic Ductal Adenocarcinoma. (2021) Authors: Nitschke, C.; Markmann, B.; Kropidlowski, J.; Goetz, M.; Tintelnot, J.; Schönlein, M.; Sinn, M.; Tölle, M.; Izbicki, J.; Pantel, K.; Wikman, H.; Uzunoglu, F.G. Journal: HPB Issue: Volume 23(2021)Supplement 3 Page Start: S681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical Utility of the 3D Tumoroid Technology in Aggressive Pancreatic Ductal Adenocarcinoma with Nodal Involvement and Poor Differentiation. (2022) Authors: Nitschke, C.; Phan, C.; Markmann, B.; Konczalla, L.; Goetz, M.; Sinn, M.; Thastrup, O.; Izbicki, J.; Sturmheit, T.; Uzunoglu, F.G. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗